Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
申请人:Pharmacia Corporation
公开号:US20040127511A1
公开(公告)日:2004-07-01
Aminocyanopyridine compounds are described which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits are also described, which include an anminocyanopyridine MK-2 inhibiting compound.
描述了能够抑制丝裂原活化蛋白激酶-2的氨基氰基吡啶化合物。还描述了包含氨基氰基吡啶MK-2抑制化合物的药物组合物和试剂盒。